| Diagnostic performance and clinical impact of 68Ga-PSMA-11 PET/CT imaging in early relapsed prostate cancer after radical therapy: a prospective multicenter study (IAEA-PSMA Study) JJ Cerci, S Fanti, EE Lobato, J Kunikowska, O Alonso, S Medina, ... Journal of Nuclear Medicine 63 (2), 240-247, 2022 | 41 | 2022 |
| The use of 68Ga DOTATATE PET/CT for diagnostic assessment and monitoring of 177Lu DOTATATE therapy in pituitary carcinoma F Novruzov, JA Aliyev, Z Jaunmuktane, JB Bomanji, I Kayani Clinical Nuclear Medicine 40 (1), 47-49, 2015 | 41 | 2015 |
| The use of multiparametric 18F-fluoro-L-3, 4-dihydroxy-phenylalanine PET/MRI in post-therapy assessment of patients with gliomas F Fraioli, A Shankar, H Hyare, V Ferrazzoli, V Militano, G Samandouras, ... Nuclear medicine communications 41 (6), 517-525, 2020 | 22 | 2020 |
| The use of 18F-FDG PET ratios in the differential diagnosis of common malignant brain tumors K Meric, RP Killeen, AS Abi-Ghanem, F Soliman, F Novruzov, E Cakan, ... Clinical Imaging 39 (6 ne bb), 970-974, 2015 | 22 | 2015 |
| Head-to-head Intra-individual Comparison of [68Ga]-FAPI and [18F]-FDG PET/CT in Patients with Bladder Cancer E Novruzov, K Dendl, H Ndlovu, PL Choyke, M Dabir, M Beu, F Novruzov, ... Molecular Imaging and Biology 24 (4), 651-658, 2022 | 21 | 2022 |
| Radiation accidents and their management: emphasis on the role of nuclear medicine professionals JB Bomanji, F Novruzov, S Vinjamuri Nuclear Medicine Communications 35 (10), 995-1002, 2014 | 20 | 2014 |
| Evaluation of neck pain with 18F-NaF PET/CT TJD Byrnes, W Xie, O Al-Mukhailed, A D’Sa, F Novruzov, ATH Casey, ... Nuclear medicine communications 35 (3), 298-302, 2014 | 14 | 2014 |
| The value of [68Ga] Ga-DOTA-TATE PET/CT in diagnosis and management of suspected pituitary tumors F Novruzov, A Aliyev, MYS Wan, R Syed, E Mehdi, I Aliyeva, F Giammarile, ... European Journal of Hybrid Imaging 5, 1-13, 2021 | 12 | 2021 |
| Metastatic insulinoma controlled by targeted radionuclide therapy with 177Lu-DOTATATE in a patient with solitary kidney and MEN-1 syndrome F Novruzov, L Mehmetbeyli, JA Aliyev, B Abbasov, E Mehdi Clinical Nuclear Medicine 44 (6), e415-e417, 2019 | 9 | 2019 |
| The impact of Ga-68 DOTATATE PET/CT imaging on management of patients with paragangliomas E Skoura, D Priftakis, F Novruzov, ME Caplin, G Gnanasegaran, ... Nuclear Medicine Communications 41 (2), 169-174, 2020 | 8 | 2020 |
| Labeling process and quality control results of 225Ac-PSMA-617 for targeted alpha particle therapy for metastatic prostate cancer R Shukurov, M Veliyev, Z Dadashov, J İsayev, F Novruzov Journal of Nuclear Medicine 60 (supplement 1), 1611-1611, 2019 | 6 | 2019 |
| Diagnostic accuracy of fine needle aspiration biopsy versus postoperative histopathology for diagnosing thyroid malignancy A Aliyev, I Aliyeva, F Giammarile, N Talibova, G Aliyeva, F Novruzov Endocrinology, Diabetes & Metabolism 5 (6), e373, 2022 | 4 | 2022 |
| Correlation between 18F-FDG PET/CT standardized uptake value with prognostic factors and gene expression profiles in breast cancer: Single center study from Azerbaijan F Novruzov, J Aliyev, S Rehimzade, S Mahmudlu, E Jumazade, ... Journal of Nuclear Medicine 60 (supplement 1), 1234-1234, 2019 | 3 | 2019 |
| Tandem therapy versus single agent 177Lu-PSMA and 225Ac-PSMA therapy of advanced stage metastatic castration resistant prostate carcinoma: Clinical trial from Azerbaijan F Novruzov, G Aliyeva, R Shukurov, S Novruzova, Z Dadashov, M Valiyev, ... Journal of Nuclear Medicine 63 (supplement 2), 2548-2548, 2022 | 2 | 2022 |
| Positive effect of Actinium 225-PSMA treatment on ECOG performance status: A case report on a patient with castration resistant stage IV prostate carcinoma. F Novruzov, JA Aliyev, Z Allahverdiyeva, E Mehdi, F Giammarile Revista Espanola de Medicina Nuclear e Imagen Molecular 38 (4), 260-261, 2019 | 2 | 2019 |
| Assessment of 68Ga-DOTATATE PET/CT in suspected pituitary tumours F Novruzov, DA Aliyev, J Bomanji, S Wan, R Sajjan, F Burzu, I Kayani Journal of Nuclear Medicine 55 (supplement 1), 1960-1960, 2014 | 2 | 2014 |
| Head to head comparison of 68Ga-FAPI-46 PET/CT and 18-FDG PET/CT in breast carcinoma staging: a clinical trial update from Azerbaijan F Novruzov, E Mehdi, N Orucova, G Aliyeva, R Shukurov, Z Dadashov, ... Journal of Nuclear Medicine 63 (supplement 2), 2372-2372, 2022 | 1 | 2022 |
| Comparison [68Ga] GaFAPI-46 PET/CT and [18F] FDG PET/CT in breast carcinoma staging: preliminary results of randomised prospective clinical trial from Azerbaijan F Novruzov, E Mehdi, N Orucova, Q Abdullayev, N Talibova, M Moore, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 48 (SUPPL 1), S49-S49, 2021 | 1 | 2021 |
| 215 QUANTITATIVE INTERIM PET IS MORE ACCURATE THAN QUALITATIVE ASSESSMENT IN PREDICTING OUTCOME IN DLBCL RL Elstrom, P Martin, L Solnes, RR Furman, J Ruan, F Novruzov, ... | 1 | 2011 |
| FDG-PET in Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy Toxicity: A Systematic Review A Al-Ibraheem, AS Abdlkadir, E Lopci, S Allouzi, D Paez, M Alkuwari, ... Cancers 16 (9), 1728, 2024 | | 2024 |
Jamshed BomanjiDrVerified email at uclh.nhs.uk
